Finance

Beta
Lists
12X1:FRA
Anavex Life Sciences Corp
€2.04
+0.94%
(+0.019) 1D
Jun 12, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 12X1...
Open
€2.04
High
€2.04
Low
€2.04
Mkt. cap
231.68M
Avg. vol.
1.15K
Volume
0.00
52-wk high
€11.50
52-wk low
€2.02
No. of employees
34
Open
€2.04
High
€2.04
Low
€2.04
Mkt. cap
231.68M
Avg. vol.
1.15K
Volume
0.00
52-wk high
€11.50
52-wk low
€2.02
No. of employees
34
News stories
From sources across the web
About Anavex Life Sciences Corp
CEOChristopher U. Missling Ph.D.
Employees34
Founded2004
HeadquartersNew York, New York, United States
SectorBiotechnology
Websiteanavex.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
9.80M
9.83M
7.15M
4.62M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.62M
4.50M
3.68M
2.13M
Operating expense
12.42M
14.33M
10.83M
6.75M
Total operating expenses
12.42M
14.33M
10.83M
6.75M
Operating income
-12.42M
-14.33M
-10.83M
-6.75M
Other non operating income
-
25.00K
-
-
EBT including unusual items
-11.20M
-13.24M
-9.83M
-5.66M
EBT excluding unusual items
-11.20M
-13.24M
-9.83M
-5.66M
Income tax expense
-
-
-
18.00K
Effective tax rate
-
-
-
-0.32%
Other operating expenses
-
-
-
-
Net income
-11.20M
-13.24M
-9.83M
-5.68M
Net profit margin
-
-
-
-
Earnings per share
-0.13
-0.16
-0.11
-0.06
Interest and investment income
1.21M
1.08M
999.00K
1.08M
Interest expense
-
-
-
-
Net interest expenses
1.21M
1.08M
999.00K
1.08M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer